Anschutz Medical Campus, University of Colorado, Mail Stop B198-2, Academic Office 1, 12631 E. 17th Avenue, Rm 4211, Aurora, CO, 80045, USA.
Fundación para la Salud Integral de los Guatemaltecos, Quetzaltenango, Guatemala.
Matern Child Health J. 2022 Jan;26(1):168-176. doi: 10.1007/s10995-021-03275-4. Epub 2021 Oct 28.
The aim of this analysis is to present initial contraceptive choices of women offered postpartum contraception in rural Guatemala.
We trained community nurses participating in the delivery of a home-based antepartum and postpartum care program in rural Guatemala in contraceptive implant placement and had them offer condoms, pills, an injection, or an implant at women's home-based 40-day postpartum visit in intervention clusters of a non-blinded, cluster-randomized trial. Women who had already started postpartum contraception or were over the age of 35 were excluded from participation. The primary outcome of the trial was contraceptive use at 3 months postpartum, so this initial analysis describes immediate preferences in the population.
Of 208 women enrolled in the study, 108 were in intervention clusters and 100 lived in control clusters. In the intervention group, 32 women declined contraception, 36 women received the injectable, 30 women had an implant placed, 5 women started pills, 2 women chose condoms, and data on 3 women were missing. In the control clusters, 43 women were planning on the injectable, 11 planned on the implant, 10 did not want to start a method, 5 planned on sterilization, 2 aimed for natural family planning, 2 wanted a copper IUD, 1 woman wanted condoms, 18 did not know, and data on 8 women were missing.
The contraceptive implant, which was not previously available in this community, had high uptake at 27.8% in the intervention group.
Clinicaltrials.gov, NCT04005391; Retrospectively Registered 7/2/2019, https://clinicaltrials.gov/ct2/show/NCT04005391 Protocol: https://doi.org/10.1186/s13063-019-3735-3.
本分析旨在介绍在危地马拉农村为接受产后避孕的女性提供服务时,她们最初选择的避孕方法。
我们培训了参与危地马拉农村家庭为基础的产前和产后护理项目的社区护士,让他们在干预组的女性产后 40 天的家庭访问时提供避孕套、药丸、注射剂或植入物,这些女性来自于一个非盲、整群随机试验的对照组。已经开始产后避孕或年龄超过 35 岁的女性被排除在研究之外。该试验的主要结果是产后 3 个月的避孕使用情况,因此本初步分析描述了该人群的即时偏好。
在这项研究中,208 名女性中,有 108 名女性在干预组,100 名女性在对照组。在干预组中,有 32 名女性拒绝了避孕,36 名女性接受了注射,30 名女性接受了植入,5 名女性开始服用药丸,2 名女性选择了避孕套,3 名女性的数据缺失。在对照组中,43 名女性计划使用注射剂,11 名女性计划使用植入物,10 名女性不打算开始使用避孕方法,5 名女性计划绝育,2 名女性希望自然计划生育,2 名女性希望使用铜宫内节育器,1 名女性希望使用避孕套,18 名女性不知道,8 名女性的数据缺失。
在这个社区以前没有使用过的避孕植入物,在干预组的使用率高达 27.8%。
Clinicaltrials.gov,NCT04005391;2019 年 7 月 2 日回顾性注册,https://clinicaltrials.gov/ct2/show/NCT04005391 方案:https://doi.org/10.1186/s13063-019-3735-3。